Skip to main content
SpringerLink
Log in

Dissolving intravenous cyclosporin A in a fat emulsion carrier prevents acute renal side effects in the rat

  • Original Articles
  • Published:
Transplant International

Abstract

Cyclosporin A (CyA)-induced nephrotoxicity is still a serious clinical problem. The nephrotoxicity seems to be more pronounced when CyA (solubilized in water with Cremophore EL, as in Sandimmun) is given intravenously than when it is given orally. Using soybean oil in which CyA was dissolved, we prepared an intravenous fat emulsion without an artificial detergent, such as Cremophore EL. The renal effects of our new formula were compared with those of Sandimmun and Cremophore EL in a rat model. CyA in the fat emulsion did not significantly affect the glomerular filtration rate (GFR). Both Sandimmun and Cremophore EL significantly reduced the GFR. These results suggest that a change in the vehicle may obviate the acute nephrotoxic side effects caused by intravenous administration of CyA solubilized by Cremophore EL.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Besarab A, Jarrell BE, Hirsch S, Carabasi RA, Cressman MD, Green P (1987) Use of the isolated perfused kidney model to assess the acute pharmacologic effects of cyclosporine and its vehicle, Cremophor EL. Transplantation 44: 195–201

    Google Scholar 

  2. Conte G, Dal Canton A, Sabbatini M, Napodano P, De Nicola L, Gigliotti G, Fuiano G, Testa A, Esposito C, Russo D, Andreucci VE (1989) Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjects. Kidney Int 36: 1086–1092

    Google Scholar 

  3. English J, Evan A, Houghton DC, Bennett WM (1987) Cyclosporine-induced acute renal dysfunction in the rat. Transplantation 44: 135–141

    Google Scholar 

  4. Górecki DC, Jakóbisiak M, Kruszewski A, Lasek W (1991) Evidence that liposome incorporation of cyclosporine reduces its toxicity and potentiates its ability to prolong survival of cardiac allografts in mice. Transplantation 52: 766–769

    Google Scholar 

  5. Hoefnagels WAJ, Gerritsen EJA, Brouwer OF, Souverijn JHM (1988) Cyclosporin encephalopathy associated with fat embolism induced by the drug's solvent (letter). Lancet II: 901

    Google Scholar 

  6. Kahan BD, Wideman CA, Flechner S, Buren CT van (1984) Anaphylactic reaction to intravenous cyclosporin (letter). Lancet I: 52

    Google Scholar 

  7. Kon V, Sugiura M, Inagami T, Harvie BR, Ichikawa I, Hoover RL (1990) Role of endothelin in cyclosporine-induced glomerular dysfunction. Kidney Int 37: 1487–1491

    Google Scholar 

  8. Land W (1987) Optimal use of SandimmunR in organ transplantation. Springer, Berlin Heidelberg New York

    Google Scholar 

  9. Lau DCW, Wong K-L, Hwang WS (1989) Cyclosporine toxicity on cultured rat microvascular endothelial cells. Kidney Int 35: 604–613

    Google Scholar 

  10. Luke DR, Kasiske BL, Matzke GR, Awni WM, Keane WE (1987) Effects of cyclosporine on the isolated perfused rat kidney. Transplantation 43: 795–799

    Google Scholar 

  11. Pichlmayr R, Wonigeit K, Ringe B, Neuhaus P, Frei U, Offner G, Brodehl J, Mihatsch MJ (1985) Morphologic lesions in Sandimmun-treated patients. In: Wiskott E (ed) SandimmunR (ciclosporin) in renal transplantation: a diagnostic and therapeutic approach to minimize nephrotoxicity. Sandoz, Basel, pp 533–543

    Google Scholar 

  12. Thiel G, Hermle M, Brunner FP (1986) Acutely impaired renal function during intravenous administration of cyclosporine A: a Cremophore side-effect. Clin Nephrol 25: 40–42

    Google Scholar 

  13. Tollemar J, Ringdén O, Tydén G (1990) Liposomal Amphotericin-B (AmBisome)R treatment in solid organ and bone marrow transplant recipients. Efficacy and safety evaluation. Clin Transplant 4: 167–175

    Google Scholar 

  14. Weir MR, Klassen DK, Shen SY, Sullivan D, Buddemeyer EU, Handwerger BS (1990) Acute effects of intravenous cyclosporine on blood pressure, renal hemodynamics and urine prostaglandin production of healthy humans. Transplantation 49: 41–47

    Google Scholar 

  15. Whiting PH, Thompson AW (1989) Pathological effects of cyclosporine A in experimental models. In: Thomson AW (ed) Sandimmun mode of action and clinical application. Kluwer, Dordrecht, pp 303–323

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Transplantation Surgery, Huddinge Hospital, S-141 86, Huddinge, Sweden

    A. Tibell

  2. Department of Nephrology, Huddinge Hospital, S-141 86, Huddinge, Sweden

    M. Larsson & A. Alvestrand

Authors
  1. A. Tibell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Larsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Alvestrand
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Tibell, A., Larsson, M. & Alvestrand, A. Dissolving intravenous cyclosporin A in a fat emulsion carrier prevents acute renal side effects in the rat. Transplant Int 6, 69–72 (1993). https://doi.org/10.1007/BF00336647

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00336647

Key words

Search

Navigation